U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06949969) titled 'Alesis OSA-1 Obstructive Sleep Apnea Treatment' on April 18.
Brief Summary: The goal of randomized clinical trial is to determine if the Alesis OSA-1 low laser light therapy device can reduce apnea-hypopnea index scores and treat sleep apnea in adult participants over the age of 18 who are diagnosed with obstructive sleep apnea (OSA). The main questions it aims to answer are]:
* Does the use of the Alesis OSA-1 device reduce the number of AHI events after six treatments of 12 minutes each, 2x per week x 3 weeks, in adult OSA patients?
Researchers will compare results of 35 control group participants who will not receive treatment...